Italy Oncology Therapeutics Market Analysis

Italy Oncology Therapeutics Market Analysis

$ 3999

By 2030, it is anticipated that the Italy Oncology Therapeutics Market will reach a value of $8 Bn from $4.3 Bn in 2022, growing at a CAGR of 7.9% during 2022-2030. The Oncology Therapeutics Market in Italy is dominated by a few domestic pharmaceutical companies such as Dompe, MolMed, and Menarini. The Oncology Therapeutics Market in Italy is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Italy Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.

ID: IN10ITPH042 CATEGORY: Pharmaceuticals GEOGRAPHY: Italy AUTHOR: Dr. Vishwa Modhia

Buy Now

Italy Oncology Therapeutics Market Analysis Summary

By 2030, it is anticipated that the Italy Oncology Therapeutics Market will reach a value of $8 Bn from $4.3 Bn in 2022, growing at a CAGR of 7.9% during 2022-2030.

Italy is a high-income, developed country located in Southern Europe comprising the boot-shaped Italian peninsula and several islands including Sicily and Sardinia. It is projected that approximately 377,000 new instances of malignant tumours will be diagnosed in Italy, with approximately 195,000 in males and approximately 182,000 in women. Every day in Italy, 1,030 people are diagnosed with cancer. Geographic comparisons reveal considerable North-South disparities in cancer prevalence in Italy. The average annual incidence rate in Central Italy and the South/Islands is lower.

Cancer is the main cause of mortality among people aged 30-69 in Italy. Cancer killed 180,085 individuals in Italy in 2017, accounting for 27.7 % of all deaths that year, with 100,123 men dying and 79,962 women dying. In Italy, alcohol consumption was responsible for 6.1 % of cancer deaths in men aged 15 and above. 7.2% of cancers are attributable to infections. Italy's government spends 9.6 % of its GDP on healthcare.

Italy Oncology Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

The 5-year survival rate in Italy is 54 % for males and 63 % for women, the highest in the European Union. The higher survival rate in women is since the most common cancer is breast cancer, which has a favourable prognosis when detected early. As a result, the national public healthcare system can give patients with effective and timely treatments. It is anticipated that more than 3.6 Mn Italians will have a cancer diagnosis by 2020, accounting for one in every 17 Italians, including 1.9 Mn women (6 % of the female population) and 1.7 Mn males (5.6 % of the male population). In Italy, tobacco smoking is the major cause of lung cancer, accounting for 85 to 90 % of cases. In Italy, the industrial sector is still highly regarded. These aspects could boost Italy Oncology Therapeutics Market.

Market Restraints

Despite the fact that Italy is a developed country with a strong healthcare system, funding for specialised research is restricted. This can make obtaining the necessary finances for research and development of new liver cancer treatments difficult. These factors may deter new entrants into the Italy Oncology Therapeutics Market.

Competitive Landscape

Key Players

  • Menarini: Menarini is an Italian multinational pharmaceutical company that develops and produces a range of cancer therapeutics, including chemotherapy drugs and targeted therapies
  • MolMed: MolMed is an Italian biotechnology company that specializes in the development of novel gene and cell therapies for the treatment of cancer. The company is currently developing several innovative CAR-T cell therapies for a range of cancer types
  • Sigma-Tau: Sigma-Tau is an Italian pharmaceutical company that develops and produces a range of cancer therapeutics, including chemotherapy drugs and targeted therapies
  • Dompe: Dompe is an Italian pharmaceutical company that focuses on the development and production of a range of cancer therapeutics, including chemotherapy drugs and immunotherapies

Notable Recent Deals

May 2022: Novartis has halted the manufacture of two cancer medications at plants in Italy and New Jersey owing to "possible quality concerns" discovered in the company's manufacturing procedures. As a result, the Swiss pharmaceutical company will temporarily suspend delivery of the two treatments, known as Lutathera and Pluvicto, while it tries to resolve the issue. Novartis stated that there is no indication of risk to patients treated with medication products previously manufactured at either of the locations and that treatment centres have been urged to monitor for any side effects.

Healthcare Policies and Reimbursement Scenarios

The Italian National Health Service manages public healthcare spending for oncological disease treatment. The Italian Medicines Agency (AIFA) is the regulatory authority in charge of the approval and regulation of therapeutic medicines, particularly cancer therapies, in Italy. The "Stati di Conoscenza" (State of Knowledge) system in Italy also evaluates and reimburses novel cancer treatments. This method permits patients suffering from life-threatening or serious conditions, such as cancer, to receive therapies that have not yet been licenced for use in Italy.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Oncology Therapeutics Segmentation

By Application (Revenue, USD Billion):

  • Blood Cancer
  • ?Colorectal Cancer
  • Gastrointestinal Cancer
  • Gynaecologic Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • ?Others

By Drugs (Revenue, USD Billion):

  • Revlimid
  • Avastin
  • Herceptin
  • Rituxan
  • Opdivo
  • Gleevec
  • Velcade
  • Imbruvica
  • Ibrance
  • Zytiga
  • Alimta
  • Xtandi
  • Tarceva
  • Perjeta
  • Temodar
  • Others

By Therapy (Revenue, USD Billion):

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • ?Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 03 April 2023
Updated by: Dhruv Joshi

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter